A global developer & provider of Glucose Continuous Monitoring system for diabetic patients
Infinovo was formed in 2016. For the past several years, Infinovo has been focusing on developing an accurate and affordable CGM (Continuous Glucose Monitoring) for patients which will be available for both Type 1 and Type 2 Diabeties. The company has developed a CGM which can compete in the global market for accuracy, durability, and design.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 1, 2019 | Series A | — | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Rays Venture Capital | — | Series A |
Prosperico Ventures | — | Series A |